BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1093300)

  • 1. The incidence of malignancies in transplant recipients.
    Penn I
    Transplant Proc; 1975 Jun; 7(2):323-6. PubMed ID: 1093300
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancers in cyclosporine-treated vs azathioprine-treated patients.
    Penn I
    Transplant Proc; 1996 Apr; 28(2):876-8. PubMed ID: 8623443
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney transplant recipients and the incidence of adverse reactions to cyclosporin.
    Tolou-Ghamari Z; Palizban AA
    Saudi Med J; 2004 Oct; 25(10):1499-500. PubMed ID: 15494834
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignancies associated with immunosuppressive or cytotoxic therapy.
    Penn I
    Surgery; 1978 May; 83(5):492-502. PubMed ID: 347611
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence and types of malignancies in renal transplant recipients in Iraq.
    Altaee IK; Jaleel NA; Aljubury HM; Alshamaa IA; Gazala S
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):408-14. PubMed ID: 16970265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.
    Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper SG; Morgan GW
    Cancer; 1999 Apr; 85(8):1758-64. PubMed ID: 10223570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease.
    Otley CC; Cherikh WS; Salasche SJ; McBride MA; Christenson LJ; Kauffman HM
    J Am Acad Dermatol; 2005 Nov; 53(5):783-90. PubMed ID: 16243126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin malignancies in renal transplant recipients: a Brazilian center registry.
    Falsarella PM; Alves-Filho G; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynecologic malignancies in immunosuppressed organ homograft recipients.
    Porreco R; Penn I; Droegemueller W; Greer B; Makowski E
    Obstet Gynecol; 1975 Apr; 45(4):359-64. PubMed ID: 1091896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in invasive disease due to Candida species following heart and lung transplantation.
    Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
    Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cancer after kidney transplant: results from the North Italy transplant program.
    Pedotti P; Cardillo M; Rossini G; Arcuri V; Boschiero L; Caldara R; Cannella G; Dissegna D; Gotti E; Marchini F; Maresca MC; Montagnino G; Montanaro D; Rigotti P; Sandrini S; Taioli E; Scalamogna M
    Transplantation; 2003 Nov; 76(10):1448-51. PubMed ID: 14657684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations in renal transplant patients.
    Amiransari B; Khallili M; Anssarin H; Bassiri A; Simforoosh N
    Transplant Proc; 1995 Oct; 27(5):2734. PubMed ID: 7482894
    [No Abstract]   [Full Text] [Related]  

  • 17. Low incidence of malignancy after transplantation in Chinese heart allograft recipients.
    Hsu RB; Chen RJ; Chou NK; Ko WJ; Wang SS; Chu SH
    Transpl Int; 2005 Mar; 18(3):283-8. PubMed ID: 15730487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with fifty human kidney transplants.
    Perdue GD; Smith RB; Lewis EL; Walton KN; Waters WC; Herndon EG
    Am Surg; 1972 Feb; 38(2):74-8. PubMed ID: 4550689
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignancies in recipients of organ transplants.
    Penn I
    Johns Hopkins Med J Suppl; 1974; 3():211-21. PubMed ID: 4608179
    [No Abstract]   [Full Text] [Related]  

  • 20. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.